Internal Medicine Alert – October 30, 2007
October 30, 2007
View Issues
-
Randomized Controlled Trial of Esomeprazole in Functional Dyspepsia Patients with Epigastric Pain and Burning
One week of acid suppression, even with esomeprazole 40 mg bid, fails to predict longer term symptom response in functional dyspepsia. -
Predicting Caregivers' Burdens
The burdens on caregivers of cognitively-impaired elderly can be correlated with measurements of the commonly used ADL (Activities of Daily Living) scales, particularly impairments in financial skills. -
LDL—Lower is Better, But How Low Should We Go?
Statin therapy in patients with a very low LDL Cholesterol level (ie, less than 60 mg/dL) appears to be safe and is associated with improved survival. -
Zoledronic Acid Injection (Reclast®)
A once yearly biophosphonate has been approved for the treatment of osteoporosis in postmenopausal women. -
Clinical Briefs By Louis Kuritzky, MD
The most recent 2007 position paper from the ADA suggest that all adults over age 45 receive screening for diabetes by a fasting blood glucose (FBG). Measurement of FBG is not always convenient for patients.